この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/8/201 分で読めます
Hospira, Inc.; Withdrawal of Approval of a New Drug Application for DEXTRAN 70
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of a new drug application (NDA) for DEXTRAN 70 (6% Dextran 70 and 0.9% NaCl or/5% Dextrose 500 mL Glass Bottle) held by Hospira, Inc., 275 North Field Dr., Lake Forest, IL 60045. Hospira, Inc., has notified the Agency in writing that this product is no longer marketed and has requested that approval of the application be withdrawn.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →